Aspiro applies for delisting from Nasdaq Stockholm

The board of directors of Aspiro AB (publ) (“Aspiro”) has decided to apply for
delisting of the Aspiro shares from Nasdaq Stockholm. The last day of trading in
the shares on Nasdaq Stockholm will be notified when Aspiro has been informed
thereof by Nasdaq Stockholm.
On 30 January 2015, Project Panther Bidco Ltd (“Panther”) announced a public
offer (the “Offer”) to the shareholders of Aspiro to tender all shares in
Aspiro. On 16 March 2015, Panther announced that Panther held 420,699,016
shares, corresponding to approximately 95.18% of the shares and votes in Aspiro.

Panther has thereafter requested that Aspiro’s board of directors applies for
the delisting of the company’s shares from Nasdaq Stockholm. Such an application
has today been made to Nasdaq Stockholm.

Panther has also requested a compulsory acquisition of the remaining shares
pursuant to Chapter 22 of the Swedish Companies Act.

Based on the above, the board of directors of Aspiro has decided to apply for
delisting of Aspiro’s shares from Nasdaq Stockholm. The last day of trading in
the shares will be announced as soon as Aspiro has been informed thereof by
Nasdaq Stockholm.

Malmö, 16 March 2015

The board of directors of Aspiro AB (publ)

Aspiro AB discloses the information provided herein pursuant to the Financial
Instruments Trading Act and/or the Securities Markets Act and the Takeover
Rules. The information was submitted for publication at 4:00 pm CET on 16 March
2015.

For questions, please contact: Trond Berger, Chairman of the Board, Phone number
+47 23 10 66 95, E-mail trond.berger@schibsted.no

Aspiro in Brief
Aspiro is a media technology company on the forefront in the ongoing
redefinition of music consumption. Through its subscription service WiMP, the
company offers a complete music experience with HiFi quality audio, HD-video and
curated editorial. In parallel, Aspiro is a content provider to the online media
industry through RADR, helping its partners to attract and retain visitors on
their web sites. For more information, please visit www.aspiro.com